| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |